1,1'- (4,4,7,7- tetramethyl- 4,7- diazaundecamethylene)bis- 4- (3- methyl- 2,3- dihydro(benzo- 1,3- thiazole)- 2- methylidene)quinolinium (TOTO)

Subscribe to Selected New Research on 1,1'-(4,4,7,7-tetramethyl-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-thiazole)-2-methylidene)quinolinium

246 relevant articles (5 outcomes, 14 trials/studies) found for this Bio-Agent

Description: cpd is non-fluorescent in solution but forms highly fluorescent complex with double-stranded DNA; RN given refers to the tetraiodide cpd

Also Known As:

TOTO; 1,1'-(4,4,7,7-tetramethyl-4-7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-thiazole)-2-methylidene)quinolinium, tetraiodide

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 23

1-Ring Heterocyclic Compounds

Azoles: 226

Thiazoles: 12

1,1'-(4,4,7,7-tetramethyl-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-thiazole)-2-methylidene)quinolinium: 246

2-Ring Heterocyclic Compounds

Quinolines: 58

Quinolinium Compounds

1,1'-(4,4,7,7-tetramethyl-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-thiazole)-2-methylidene)quinolinium: 246

Organic Chemicals: 40

Sulfur Compounds: 82

Thiazoles: 12

1,1'-(4,4,7,7-tetramethyl-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-thiazole)-2-methylidene)quinolinium: 246

Experts

1.	Suzuki, Yohey: 2 articles (01/2006 - 11/2004)
2.	Hirayama, Hisako: 2 articles (01/2006 - 11/2004)
3.	Horikoshi, Koki: 2 articles (01/2006 - 11/2004)
4.	Nakagawa, Tatsunori: 2 articles (01/2006 - 11/2004)
5.	Takai, Ken: 2 articles (01/2006 - 11/2004)
6.	Tsunogai, Urumu: 1 article (01/2006)
7.	Konno, Uta: 1 article (01/2006)
8.	Nealson, Kenneth H: 1 article (11/2004)
9.	Paterson, B L: 1 article (12/2000)

Related Diseases

1.	Infection 12/01/1999 - "Thus, in toto, brain microvascular endothelial cells might contribute to the neuropathogenesis of HIV-1 infection." 01/01/1992 - "Protection must be tested on natural hosts with a reference vaccine (S19 or Rev. 1) by the agreed method which reproduces the natural infection and measures immunity in toto" 01/01/2003 - "At the end of the treatment period, out of the 129 patients with fungal infections treated with Toto ointment alone, 92 (71.3)% were successfully treated; while 41 (87.2%) out of the 47 patients with scabies were successfully treated with Toto ointment alone" 01/01/1993 - "The protocols in toto have shown acyclovir (ACV) to be safe and effective for treatment of nearly all forms of acute VZV infection" 05/01/2007 - "Our results in toto support a model suggesting that during infection, the N and P proteins enter the nucleus independently, that viroplasm formation requires homologous N-protein interactions, and that P protein targeting to the viroplasm requires N-P protein interactions that occur after N and P protein import into the nucleus." Order ALL the reference details at left...
2.	Cysts 03/01/2004 - "INTERVENTION: Symptoms were relieved by evacuation of the cyst content by means of a Rickam's reservoir, and the lesion was subsequently removed in toto" 09/01/2008 - "We diagnosed a nasolabial cyst, which was extirpated in toto through a combined transvestibular-transnasal approach." 07/01/2008 - "The cyst was removed in toto from the eye by double incision technique" 07/01/2007 - "Surgery was successful with respect to in-toto removal of the intradural, extramedullary cyst, reversal of cord compression and symptoms" 01/01/2007 - "In toto, six of the seven cysts (86%) were found in an inferior parathyroid gland" Order ALL the reference details at left...
3.	Leukemia 08/01/1996 - "In 1993 after 6 years in complete remission, she presented with an intracutaneous nodular mass on her right upper arm which was resected in toto and shown to be undifferentiated monoblastic leukemia" 12/01/1989 - "In toto, the results suggest that T3c is similar or perhaps identical with the novel TL product previously identified on the surface of certain x-ray-induced BALB/c leukemias." Order ALL the reference details at left...
4.	Coronary Artery Disease (Coronary Atherosclerosis) 01/01/1980 - "As a clinical toto, the radionuclide procedures are currently more useful than ultrasound examination in evaluating patients with known or suspected coronary artery disease" 12/01/1975 - "The authors graphically studied the topographic pattern and severity of coronary arteriosclerosis in arteriosclerotic heart disease (ASHD) sudden deaths using an improved technique involving in toto removal and decalcification of the main coronary tree" Order ALL the reference details at left...
5.	Liver Cirrhosis (Hepatic Cirrhosis) 07/01/1950 - "Presumed therapeutic efficacy of transfusion of ascitic fluid and blood in toto in hepatic cirrhosis.]" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Acyclovir (Aciclovir)
2.	Lipoproteins (Lipoprotein)
3.	Sulfur
4.	Malate Dehydrogenase (Dehydrogenase, Malate)
5.	Insulin (Novolin)
6.	Electron Transport Complex IV (Cytochrome c Oxidase)
7.	beta Catenin
8.	A-Form DNA (A-DNA)
9.	Intercellular Signaling Peptides and Proteins (Growth Factors)
10.	Selective Estrogen Receptor Modulators (SERM)

Related Therapies and Procedures

1.	Laser Therapy (Surgery, Laser)
2.	Trabeculectomy (Trabeculoplasty)
3.	Surgical Instruments (Clip)
4.	Ovariectomy (Oophorectomy)
5.	Hysterectomy

Best Treatments:
Research Summary Report
on Infection

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 13871 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>